Top Stock Movers Today | Top Stock Gainers & Top Stock Losers

Stock Movers

Gainers

TickerCompany±%Buy Stock
Loading...
Get in real-time

Loser

TickerCompany±%Buy Stock
Loading...
Get in real-time

Stock Movers

Gainers

TickerCompany±%Buy Stock
NUVOHoldco Nuvo Group DG$5.48168.63%14.9MBuy/Sell
SGEStrong Global$2.50119.28%1.2MBuy/Sell
XBPXBP Europe Holdings$3.4261.32%1.2MBuy/Sell
PLTNPlutonian Acquisition$9.4056.4%55.3KBuy/Sell
PRFTPerficient$73.1952.14%495.6KBuy/Sell
MULNMullen Automotive$6.0745.73%3.4MBuy/Sell
PLTNUPlutonian Acquisition$9.9543.78%1.6KBuy/Sell
MINFT$8.5542.02%116.9KBuy/Sell
NRXPNRX Pharmaceuticals$2.9841.9%398KBuy/Sell
IBACRIB Acquisition Corp. - Right$0.1035.77%182.4KBuy/Sell
MNTXManitex International$7.5434.16%61.5KBuy/Sell
GRFXGraphex Gr$0.3030.9%241.8KBuy/Sell
RYDERyde Group$5.5928.8%319.4KBuy/Sell
GGRGogoro$1.9026.66%242.2KBuy/Sell
GCTKGlucoTrack$0.7725.75%202.4KBuy/Sell
NNVCNanoviricides$1.4124.77%46KBuy/Sell
MSSMaison Solutions$1.3424.07%189.6KBuy/Sell
XELAExela Technologies$2.6023.21%162.8KBuy/Sell
UPLDUpland Software$3.1923.16%627.2KBuy/Sell
LCTXLineage Cell Therapeutics$1.3023.11%989.1KBuy/Sell
Get in real-time

Loser

TickerCompany±%Buy Stock
LYRALyra Therapeutics$0.52-87.16%2.1MBuy/Sell
GLYCGlycoMimetics$0.31-82.83%1.2MBuy/Sell
IFNrIndia Fund, Inc. (The) Rights (expiring May 14, 2024) Rights$0.03-53.39%799.6KBuy/Sell
EYPTEyePoint Pharmaceuticals$11.17-43.41%1.1MBuy/Sell
GLLIRGlobalink Investment Inc. - Rights$0.09-27.95%1.8KBuy/Sell
MMATMeta Materials$2.44-27.17%356.2KBuy/Sell
LPTVLoop Media$0.24-25.44%220KBuy/Sell
MNDRMobile-health Network$2.53-25.38%6.1MBuy/Sell
AFIBAcutus Medical$0.11-25.37%1.1MBuy/Sell
AQUNRAquaron Acquisition Corp. - Rights$0.19-24%5.8KBuy/Sell
MARXRMars Acquisition Corp. - Rights$0.23-23.34%6KBuy/Sell
COCHEnvoy Medical$3.40-21.84%443.5KBuy/Sell
HWHHWH International$1.55-21.07%1.5MBuy/Sell
IARTIntegra Lifesciences$23.07-20.15%891.3KBuy/Sell
ORGNOrigin Mat$0.93-18.43%2.1MBuy/Sell
SGDSafe & Green Development$0.50-18.32%1.7MBuy/Sell
OLBOLB Gr$3.87-17.66%22.2KBuy/Sell
BURUNuburu$0.19-16.53%1MBuy/Sell
BSGMBioSig Technologies$1.43-16.38%1.2MBuy/Sell
ELYMEliem Therapeutics$8.55-15.81%855.3KBuy/Sell
Get in real-time
Session: May 3, 2024 4:00PM EDT - May 6, 2024 3:59PM EDT

Stock News of the Day

Best Stock Promotion Right Now

Webull Promotion!
Webull Promotion!
Make a deposit of $100 or more into your account, maintain your funds to get 60 FREE fractional shares! Each share is valued between $3 - $3000!
Disclosure: All investments involve risk, and there is always the possibility that you may lose money when you invest in securities or other financial products. The value of a given security may increase or decrease, and investors may lose money, including their original investment. You should consider your investment objectives carefully before investing. Webull Financial LLC, member FINRA & SIPC. Regulatory and Exchange Fees may apply.

Best Online Stock Brokers

Claim Exclusive Offers

Wall Street Stutters After Disney, Palantir Earnings Frustrate: Apple Event, Hawkish Fed Speech In Focus While Analyst Insists 'Bull Market Is Back'
Uber's Low Growth-Adjusted Multiple Creates An Attractive Entry Point: Morgan Stanley
BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Outstanding Orladeyo Performance
Uber's Low Growth-Adjusted Multiple Creates An Attractive Entry Point: Morgan Stanley
BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Outstanding Orladeyo Performance
What's Going On With Micron Tech Stock On Monday?
Why Is Medical Device Maker Integra LifeSciences Stock Falling On Monday?

Best Online Stock Brokers

Claim Exclusive Offers

Movers Recent News

Why Zeta Global Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Why Rivian Stock Is Charging Up Premarket Today
Ahead of a crucial earnings report, Rivian shares have taken off, although the upward move could be due to a reason unrelated to earnings.
Why BP Shares Are Trading Lower Premarket Today
BP shares trading lower on Q1 FY24 results, sales at $48.88B, below consensus of $55.08B. Production down 3.5% Y/Y, Renewables pipeline at 58.5GW, Adjusted EBITDA at $10.3B, RC profit at $0.97/ADS, operating cash flow at $5.01B, net debt reduced to $24.02B. CEO optimistic about strategy, announces dividend of 7.270 cents per share. Q2 FY24 outlook: slightly lower production, guidance for higher production in FY24, capital expenditure of $16B, divestment proceeds of $2B-$3B.
Why Beauty Company Coty's Shares Are Gaining Today
Coty impresses with 8% YoY sales growth in Q3 FY24, outpacing estimates. Robust performance driven by strong sales across all regions, with a notable 10% LFL revenue increase. Prestige and Consumer Beauty segments both show solid gains, contributing to overall growth.
AudioCodes Reports Downbeat Earnings, Joins Trupanion, Palantir Technologies And Other Big Stocks Moving Lower In Tuesday Pre-Market Session
Bitcoin, Ethereum, Dogecoin Dip After Robinhood Gets Wells Notice From SEC — Analyst Says ETHs Weak Fundamentals A 'Roadblock' For King Crypto
Major cryptocurrencies witnessed a drop on Monday as another top cryptocurrency company stared at an enforcement action by U.S. regulators.
Rocket Lab USA Reports Mixed Q1 Results: EPS Beat, Sales Miss
Rocket Lab reported quarterly losses of 9 cents per share which beat the analyst consensus estimate of losses of 10 cents by 10% and represents a 10% increase over losses of 10 cents per share from the same period last year.
Cannabis Stocks Retreat On New Rescheduling Order Developments: What's Going On?
The DEA was expected to move forward with its plans this week to remove cannabis as a Schedule 1 drug, where it currently sits alongside heroin and LSD, but new reports suggest the proposal has stalled.
Symbotic Shares Gain On Strong Q2 Sales: The Details
Symbotic reported quarterly losses of 7 cents per share which missed the analyst consensus estimate of 5 cents by 40%.
Hims & Hers Health Reports Better-Than-Expected Q1 Results, Strong Guidance
Hims & Hers Health reported quarterly GAAP earnings of 5 cents per share which beat the analyst consensus estimate of 2 cents by 150%.
Palantir Q1 Earnings: Revenue Beat And Raise, US Commercial Growth, Continued GAAP Profitability And More
Palantir said first-quarter revenue increased 21% year-over-year to $634 million, which beat the consensus estimate of $625.431 million. Palantir reported adjusted earnings of 8 cents per share, which was in line with analyst estimates. The company has now delivered six straight quarters of GAAP profitability.
Lucid Q1 Earnings Highlights: Revenue Beat, EPS Miss, Production Update And More
Lucid reported first-quarter financial results Monday. Here are the key highlights and what's next for the EV company.
FAA Opens New Investigation Into Boeing 787: Did Employees Falsify Aircraft Records?
Boeing Company shares are trading lower Monday after the FAA opened a new investigation related to the company's inspections of its 787 Dreamliner. According to a Seattle Times report, the FAA said Boeing notified the agency in April that it may not have completed required inspections related to the electrical safeguards of bonding and grounding where the wings join the fuselage on some aircraft.
Why Outset Medical Shares Are Up Today
Outset said that it has resumed distribution of TabloCart with prefiltration and has product available to ship to customers in the United States.
Why Strong Global Stock Is Soaring
Strong Global Entertainment, Inc. shares are trading higher Monday after the company announced the proposed acquisition of Strong/MDI Screen Systems, Inc. by FG Acquisition Corp. In connection with the closing of the acquisition, the corporation intends to rename itself Saltire Holdings, Ltd.
What's Going On With Nvidia's Stock?
Analysts remain bullish on Nvidia, with a consensus price target of $949.36 a share and a rating of "Buy" for the stock, with the most recent ratings citing a potential upside of 31.5% from the current price. Nvidia is set to report its first-quarter financial results on May 22 after the market close. According to estimates from Benzinga Pro, analysts expect the company to report earnings of $5.55 per share and quarterly revenue of $22.103 billion.

Explore Benzinga's Financial Tools

Find Stocks Tailored to Your Trading Interests
Find Stocks Tailored to Your Trading Interests
Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Compare Benzinga's Favorite Stock Brokers

Claim Exclusive Offers

Compare Benzinga's Favorite Cryptocurrency Brokers

Claim Exclusive Offers